Apathy Diagnosis , Assessment , and Treatment in Alzheimer ’ s Disease
暂无分享,去创建一个
[1] A. Beck,et al. An inventory for measuring depression. , 1961, Archives of general psychiatry.
[2] J. Gerlach,et al. Behavioral aspects of serotonin-dopamine interaction in the monkey. , 1985, European journal of pharmacology.
[3] A. Phillips,et al. Dopamine and preparatory behavior: I. Effects of pimozide. , 1987, Behavioral neuroscience.
[4] R. Marin. Differential diagnosis and classification of apathy. , 1990, The American journal of psychiatry.
[5] R. Marin,et al. Reliability and validity of the apathy evaluation scale , 1991, Psychiatry Research.
[6] R. Marin,et al. Apathy: a neuropsychiatric syndrome. , 1991, The Journal of neuropsychiatry and clinical neurosciences.
[7] H. Mayberg,et al. Reliability, validity, and clinical correlates of apathy in Parkinson's disease. , 1992, The Journal of neuropsychiatry and clinical neurosciences.
[8] J. T. Coull,et al. Tryptophan depletion in normal volunteers produces selective impairments in learning and memory , 1994, Neuropharmacology.
[9] M. Mega,et al. The Neuropsychiatric Inventory , 1994, Neurology.
[10] Joseph James Duffy,et al. Apathy: a treatable syndrome. , 1995, The Journal of neuropsychiatry and clinical neurosciences.
[11] B L Miller,et al. Cerebral blood flow correlates of apathy in Alzheimer disease. , 1996, Archives of neurology.
[12] K. Yoshimoto,et al. Possibility of 5-HT3 receptor involvement in alcohol dependence: a microdialysis study of nucleus accumbens dopamine and serotonin release in rats with chronic alcohol consumption. , 1996, Alcoholism, clinical and experimental research.
[13] S. Kapur,et al. Serotonin-dopamine interaction and its relevance to schizophrenia. , 1996, The American journal of psychiatry.
[14] P. De Deurwaerdère,et al. Serotonin Enhances Striatal Dopamine Outflow In Vivo Through Dopamine Uptake Sites , 1996, Journal of neurochemistry.
[15] K. Berridge. Food reward: Brain substrates of wanting and liking , 1996, Neuroscience & Biobehavioral Reviews.
[16] O. Magnusson,et al. Influence of 5-HT1B/1D receptors on dopamine release in the guinea pig nucleus accumbens: a microdialysis study , 1997, Neuroscience Letters.
[17] S. Walsh,et al. Serotonergic mechanisms involved in the discriminative stimulus, reinforcing and subjective effects of cocaine , 1997, Psychopharmacology.
[18] M. Millan,et al. Serotonin (5-HT)2C receptors tonically inhibit dopamine (DA) and noradrenaline (NA), but not 5-HT, release in the frontal cortex in vivo , 1998, Neuropharmacology.
[19] Art Noda,et al. A Follow-Up Study of Actigraphic Measures in Home-Residing Alzheimer's Disease Patients , 1998, Journal of geriatric psychiatry and neurology.
[20] P. De Deurwaerdère,et al. Opposite Change of In Vivo Dopamine Release in the Rat Nucleus Accumbens and Striatum That Follows Electrical Stimulation of Dorsal Raphe Nucleus: Role of 5-HT3 Receptors , 1998, The Journal of Neuroscience.
[21] K. Berridge,et al. What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience? , 1998, Brain Research Reviews.
[22] S. Kapur,et al. Clinical and theoretical implications of 5-HT2 and D2 receptor occupancy of clozapine, risperidone, and olanzapine in schizophrenia. , 1999, The American journal of psychiatry.
[23] M. Posner. The Brain and Emotion , 1999, Nature Medicine.
[24] T. Robbins,et al. Tryptophan depletion impairs stimulus-reward learning while methylphenidate disrupts attentional control in healthy young adults: implications for the monoaminergic basis of impulsive behaviour , 1999, Psychopharmacology.
[25] B. Winblad,et al. The occurrence of depressive symptoms in the preclinical phase of AD , 1999, Neurology.
[26] N. Volkow,et al. Association between age-related decline in brain dopamine activity and impairment in frontal and cingulate metabolism. , 2000, The American journal of psychiatry.
[27] Kelly J. Murphy,et al. Differentiation of states and causes of apathy. , 2000 .
[28] Richard G. Brown,et al. Negative symptoms: the ‘pathology’ of motivation and goal-directed behaviour , 2000, Trends in Neurosciences.
[29] A. Kelley,et al. Serotonin-Dopamine Interactions in the Control of Conditioned Reinforcement and Motor Behavior , 2001, Neuropsychopharmacology.
[30] G. Malandain,et al. Perfusion Brain SPECT and Statistical Parametric Mapping Analysis Indicate That Apathy Is a Cingulate Syndrome: A Study in Alzheimer's Disease and Nondemented Patients , 2001, NeuroImage.
[31] S. Starkstein,et al. Syndromic validity of apathy in Alzheimer's disease. , 2001, The American journal of psychiatry.
[32] Charles J. Wilson,et al. Cholinergic interneuron characteristics and nicotinic properties in the striatum. , 2002, Journal of neurobiology.
[33] H. Caci,et al. The Apathy Inventory: assessment of apathy and awareness in Alzheimer's disease, Parkinson's disease and mild cognitive impairment , 2002, International journal of geriatric psychiatry.
[34] Jacques Darcourt,et al. Brain perfusion in Alzheimer's disease with and without apathy: a SPECT study with statistical parametric mapping analysis , 2002, Psychiatry Research: Neuroimaging.
[35] K. Berridge,et al. Erratum to: “Parsing reward” [Trends Neurosci. 26 (2003) 507–513] , 2003, Trends in Neurosciences.
[36] P. Boyle,et al. Treating Apathy in Alzheimer’s Disease , 2003, Dementia and Geriatric Cognitive Disorders.
[37] K. Berridge,et al. Parsing reward , 2003, Trends in Neurosciences.
[38] K. Berridge. Comparing the emotional brains of humans and other animals. , 2003 .
[39] Saori C. Tanaka,et al. Prediction of immediate and future rewards differentially recruits cortico-basal ganglia loops , 2004, Nature Neuroscience.
[40] A. Pfeffer,et al. Prevalence of major and minor depression in elderly persons with mild cognitive impairment—MADRS factor analysis , 2004, International journal of geriatric psychiatry.
[41] T. Svensson,et al. Ritanserin, a 5-HT2 receptor antagonist, activates midbrain dopamine neurons by blocking serotonergic inhibition , 2004, Psychopharmacology.
[42] J. Darcourt,et al. Brain perfusion correlates of the apathy inventory dimensions of Alzheimer's disease , 2004, International journal of geriatric psychiatry.
[43] L. Provinciali,et al. Motivational Symptoms of Depression Mask Preclinical Alzheimer’s Disease in Elderly Subjects , 2004, Dementia and Geriatric Cognitive Disorders.
[44] P. Scheltens,et al. Behavioral symptoms in mild cognitive impairment , 2004, Neurology.
[45] Magda Tsolaki,et al. Grouping for behavioral and psychological symptoms in dementia: clinical and biological aspects. Consensus paper of the European Alzheimer disease consortium , 2005, European Psychiatry.
[46] D. Stuss,et al. Apathy: why care? , 2005, The Journal of neuropsychiatry and clinical neurosciences.
[47] J. Becker,et al. Non-cognitive symptoms in mild cognitive impairment subjects , 2005, Neurocase.
[48] R. Robinson,et al. A prospective longitudinal study of apathy in Alzheimer’s disease , 2005, Journal of Neurology, Neurosurgery & Psychiatry.
[49] Karl Herholz,et al. Regional cerebral metabolism in early Alzheimer’s disease with clinically significant apathy or depression , 2005, Biological Psychiatry.
[50] C. Jack,et al. Brain atrophy rates predict subsequent clinical conversion in normal elderly and amnestic MCI , 2005, Neurology.
[51] R. Mizrahi,et al. On the overlap between apathy and depression in dementia , 2005, Journal of Neurology, Neurosurgery & Psychiatry.
[52] Masayuki Matsuda,et al. Four subgroups of Alzheimer's disease based on patterns of atrophy using VBM and a unique pattern for early onset disease , 2006, NeuroImage.
[53] J Darcourt,et al. Lack of initiative and interest in Alzheimer's disease: a single photon emission computed tomography study , 2006, European journal of neurology.
[54] P Sockeel,et al. The Lille apathy rating scale (LARS), a new instrument for detecting and quantifying apathy: validation in Parkinson’s disease , 2006, Journal of Neurology, Neurosurgery & Psychiatry.
[55] B. Dubois,et al. Neuropsychological Performance in Mild Cognitive Impairment with and without Apathy , 2006, Dementia and Geriatric Cognitive Disorders.
[56] René Hen,et al. Hippocampal Neurogenesis: Regulation by Stress and Antidepressants , 2006, Biological Psychiatry.
[57] B. Dubois,et al. Apathy and the functional anatomy of the prefrontal cortex-basal ganglia circuits. , 2006, Cerebral cortex.
[58] Afshin Borhani Haghighi,et al. Does Serotonin Augmentation Have Any Effect on Cognition and Activities of Daily Living in Alzheimer's Dementia?: A Double-Blind, Placebo-Controlled Clinical Trial , 2007, Journal of clinical psychopharmacology.
[59] S. Walther,et al. Actigraphy in agitated patients with dementia. Monitoring treatment outcomes. , 2007, Zeitschrift fur Gerontologie und Geriatrie.
[60] B. Dubois,et al. Importance of lack of interest in patients with mild cognitive impairment. , 2008, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.
[61] Annalena Venneri,et al. Neuroanatomical correlates of neuropsychiatric symptoms in Alzheimer's disease. , 2008, Brain : a journal of neurology.
[62] B. Vellas,et al. P3-135: Course of neuropsychiatric symptoms during a four year follow-up in the REAL-FR cohort , 2008, Alzheimer's & Dementia.
[63] A. Leentjens,et al. The nosological position of apathy in clinical practice , 2008, Journal of Neurology, Neurosurgery, and Psychiatry.
[64] H. Lavretsky. Neuropsychiatric symptoms in Alzheimer disease and related disorders: why do treatments work in clinical practice but not in the randomized trials? , 2008, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.
[65] B. Vellas,et al. Apathy and depression in Alzheimer's disease are associated with functional deficit and psychotropic prescription , 2008, International journal of geriatric psychiatry.
[66] H. Caci,et al. Striatal dopamine transporter levels correlate with apathy in neurodegenerative diseases A SPECT study with partial volume effect correction , 2008, Clinical Neurology and Neurosurgery.
[67] Lippincott Williams Wilkins,et al. THERMOREGULATION: RECENT CONCEPTS AND REMAINING QUESTIONS , 2008, Neurology.
[68] F. Verhey,et al. Pharmacological Treatment of Apathy in Neurodegenerative Diseases: A Systematic Review , 2009, Dementia and Geriatric Cognitive Disorders.
[69] M Benoit,et al. Persistent apathy in Alzheimer's disease as an independent factor of rapid functional decline: the REAL longitudinal cohort study , 2009, International journal of geriatric psychiatry.
[70] K. Dujardin,et al. Proposed diagnostic criteria for apathy in Alzheimer’s disease and other neuropsychiatric disorders , 2009, European Psychiatry.
[71] David Eidelberg,et al. Cholinergic modulation of the cerebral metabolic response to citalopram in Alzheimer's disease. , 2009, Brain : a journal of neurology.
[72] G. Bernardi,et al. Dopamine Modulates Cholinergic Cortical Excitability in Alzheimer's Disease Patients , 2009, Neuropsychopharmacology.
[73] A. Padovani,et al. Differential Impact of Apathy and Depression in the Development of Dementia in Mild Cognitive Impairment Patients , 2009, Dementia and Geriatric Cognitive Disorders.
[74] P. Andersen,et al. Antidepressants and dementia. , 2009, Journal of affective disorders.